Boston Scientific (NYSE:BSX) and Revolutions Medical (OTCMKTS:RMCP) Financial Contrast

Boston Scientific (NYSE:BSX) and Revolutions Medical (OTCMKTS:RMCP) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation.

Risk and Volatility

Boston Scientific has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Comparatively, Revolutions Medical has a beta of -0.43, suggesting that its stock price is 143% less volatile than the S&P 500.

Insider & Institutional Ownership

89.1% of Boston Scientific shares are held by institutional investors. 0.5% of Boston Scientific shares are held by company insiders. Comparatively, 10.5% of Revolutions Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Boston Scientific and Revolutions Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Boston Scientific	12.00%	16.59%	9.22%
Revolutions Medical	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Boston Scientific and Revolutions Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	0	2	18	1	2.95
Revolutions Medical	0	0	0	0	N/A

Boston Scientific presently has a consensus price target of $85.38, indicating a potential upside of 2.49%. Given Boston Scientific’s higher possible upside, equities analysts plainly believe Boston Scientific is more favorable than Revolutions Medical.

Earnings & Valuation

This table compares Boston Scientific and Revolutions Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$14.24 billion	8.62	$1.59 billion	$1.19	70.01
Revolutions Medical	N/A	N/A	N/A	N/A	N/A

Boston Scientific has higher revenue and earnings than Revolutions Medical.

Summary

Boston Scientific beats Revolutions Medical on 9 of the 10 factors compared between the two stocks.

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

About Revolutions Medical

Revolutions Medical Corporation, a development stage company, is engaged in the design, development, and commercialization of auto retractable vacuum safety syringes in the United States and internationally. The company develops RevVac auto retractable vacuum safety syringe, which is designed to reduce accidental needle stick injuries and lower the spread of blood borne diseases. It is also developing a suite of magnetic resonance imaging software tools consisting of RevColor, Rev3D, RevDisplay, and RevScan that are designed to enhance general diagnostic confidence through education and research use. The company sells its products to acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons through distributors. Revolutions Medical Corporation was founded in 1996 and is headquartered in Charleston, South Carolina.